A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
UW Health's Dr. Bill Hartman discusses ways to slow down aging, a study that says high school student's aren't getting enough ...
In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...
Researchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...
The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.